Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-001202
Filing Date
2013-01-03
Accepted
2013-01-03 17:29:39
Documents
1
Period of Report
2013-01-02

Document Format Files

Seq Description Document Type Size
1 DR. GERALD MCMAHON JANUARY 2013 OPTION GRANT rrd365623.html 4  
1 DR. GERALD MCMAHON JANUARY 2013 OPTION GRANT rrd365623.xml 4 3299
  Complete submission text file 0001181431-13-001202.txt   4690
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
McMahon Gerald PhD (Reporting) CIK: 0001290747 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 13508323